Norplat-S 75mg/ 75mg Tablet

Țară: Filipine

Limbă: engleză

Sursă: FDA (Food And Drug Administration)

Ingredient activ:

Clopidogrel , Aspirin

Disponibil de la:

Getz Pharma Phils., Inc.

INN (nume internaţional):

Clopidogrel + Aspirin

Dozare:

75mg/ 75mg

Forma farmaceutică:

Tablet

Unități în pachet:

Alu-Alu Blister Pack x 10's (Box of 10's)

Produs de:

Getz Pharma (Private) Limited, Pakistan

Indicații terapeutice:

For the reduction of thrombotic events in patients with recent myocardial infarction, recent stroke, or established peripheral arterial disease. Used prophylactically in patients at risk of thromboembolic disorders such as myocardial infarction, peripheral arterial disease and stroke. For acute coronary syndrome (unstable angina/non-Q-wave MI).

Data de autorizare:

2022-01-17

Caracteristicilor produsului

−
With hypersensitivity to salicylates (bronchospasm, anaphylactic
reactions).
−
With haemorrhagic disease.
−
With severe hepatic function impairment.
−
Who are pregnant.
−
Who are lactating.
PRECAUTIONS
Full blood count should be performed before starting treatment with
clopidogrel+aspirin combination and every two weeks during the first
three months of therapy. If clopidogrel is discontinued during this
period,
a full blood count should be performed within two weeks of stopping
treatment.
Aspirin should be used with caution in
−
Children or teenagers with chickenpox, influenza or fever.
−
Patients who are allergic to ibuprofen or other NSAID medicines.
−
Patients with chronic or recurrent stomach or duodenal ulcers or
digestive hemorrhages.
−
Patients with severe renal disease.
−
Patients suffering from allergic diseases like asthma or urticaria.
−
Patients suffering from gout.
Clopidogrel should be used with caution
−
In patients who may be at risk of increased bleeding from trauma,
surgery, or other pathological conditions.
−
If a patient is to undergo elective surgery, consideration should
be
given to stopping clopidogrel 5 days before surgery.
−
In patients who have lesions with a propensity to bleed (such as
ulcers). Drugs that might induce such lesions should be used in
caution in patients taking clopidogrel.
_Hepatic Impaired Patients_
Experience is limited in patients with severe hepatic disease, who may
have bleeding diatheses. Clopidogrel+Aspirin combination should be
used with caution in such patients.
_Renal Impaired Patients_
Experience is limited in patients with severe renal impairment.
Clopidogrel+Aspirin combination should be used with caution in such
patients.
DRUG INTERACTIONS
_Anticoagulants, coumarin, heparin, or thrombolytic agents:_
Clopidogrel+Aspirin combination may cause hypoprothrombinaemia
leading to increased anticoagulation and risk of bleeding when given
concomitantly with anticoagulants, coumarin, heparin, or thrombolytic
agents.
_Nonsteroidal Anti-Inf